Ipilimumab: tested in a combination
412 studies: another drug in the study is under test too. Page 5 of 5. Open to participants first (80), then studies with results posted, then the rest; newest registration first within each.
- A Combination of Ipilimumab and Fotemustine for Treat Unresectable Locally Advanced or Metastatic MelanomaCompletedNCT01654692Phase 2Report a problem
- A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumoral Interleukin-2CompletedNCT01480323Phase 2Report a problem
- IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic MelanomaWithdrawnNCT01409187Phase 1/2Report a problem
- IPI Biochemotherapy for Chemonaive Patients With Metastatic MelanomaTerminatedNCT01409174Phase 1Report a problem
- Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in MelanomaCompletedNCT01363206Phase 2Report a problem
- Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV MelanomaCompletedNCT01176474Phase 1Report a problem
- Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV MelanomaCompletedNCT00790010Phase 1Report a problem
- Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV MelanomaWithdrawnNCT00357461Phase 2Report a problem
- Monoclonal Antibody With or Without gp100 Peptides Plus Montanide ISA-51 in Treating Patients With Stage IV MelanomaCompletedNCT00077532Phase 2Report a problem
- Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV MelanomaCompletedNCT00032045Phase 2Report a problem
- Novel Adjuvants for Peptide-Based Melanoma VaccinesCompletedNCT00028431Phase 1Report a problem
- Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During SurgeryCompletedNCT00025181Phase 1Report a problem